Nova Eye Medical Overview

  • Year Founded
  • 1970

Year Founded

  • Status
  • Public

  • Employees
  • 301

Employees

  • Stock Symbol
  • EYE

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.11
  • (As of Thursday Closing)

Nova Eye Medical General Information

Description

Nova Eye Medical Ltd designs, develops, manufactures, markets and sells glaucoma surgical devices (GSD) for the market. Its devices are used by ophthalmic surgeons to reduce intraocular pressure (IOP) in patients with glaucoma. The company earns all its revenues from the sales of surgical devices for the treatment of glaucoma. Its AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser; a potential treatment to delay progression to late-stage AMD for patients who have the disease in its intermediate stage. Its segments include Glaucoma Surgical Devices segment includes the design, manufacture, marketing and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device; and AlphaRET.

Contact Information

Formerly Known As
Ellex Medical Lasers
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 107 Rundle Street
  • Kent Town, South Australia 5067
  • Australia
Primary Industry
Surgical Devices
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • 107 Rundle Street
  • Kent Town, South Australia 5067
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nova Eye Medical Stock Performance

As of 19-Nov-2026, Nova Eye Medical’s stock price is $0.11. Its current market cap is $30.6M with 285M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.11 $0.11 $0.07 - $0.14 $30.6M 285M 200K

Nova Eye Medical Financials Summary

As of 30-Sep-2026, Nova Eye Medical has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 27,880 20,702 21,187 32,549
Revenue 23,619 18,936 15,286
EBITDA (1,380) (4,351) (3,837)
Net Income (2,935) (5,861) (5,760)
Total Assets 14,857 17,312 19,973
Total Debt 1,648 1,971 2,238
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nova Eye Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nova Eye Medical‘s full profile, request access.

Request a free trial

Nova Eye Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Nova Eye Medical Ltd designs, develops, manufactures, markets and sells glaucoma surgical devices (GSD) for the market.
Surgical Devices
Kent Town, Australia
301 As of 2018

Daejeon, South Korea
 

Mason, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nova Eye Medical Competitors (8)

One of Nova Eye Medical’s 8 competitors is Wontech Co., a Formerly VC-backed company based in Daejeon, South Korea.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Wontech Co. Formerly VC-backed Daejeon, South Korea
Atricure Formerly VC-backed Mason, OH
IRIDEX Formerly VC-backed Mountain View, CA
DUKE Empirical Private Equity-Backed Morgan Hill, CA
Staar Surgical Corporation Lake Forest, CA
You’re viewing 5 of 8 competitors. Get the full list »

Nova Eye Medical Patents

Nova Eye Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025524963-A Apparatus and method for determining the location of an object of interest in a patient's eye, and ophthalmic apparatus Pending 25-Jul-2022
AU-2023315289-A1 Device and method for determining location of an object of interest within an eye of a patient, and ophthalmic apparatus Pending 25-Jul-2022
EP-4311475-A1 Device and method for determining location of an object of interest within an eye of a patient, and ophthalmic apparatus Pending 25-Jul-2022
US-20250169692-A1 Device and method for determining location of an object of interest within an eye of a patient, and ophthalmic apparatus Pending 25-Jul-2022
US-20260033719-A1 Device and method for determining location of an object of interest within an eye of a patient, and ophthalmic apparatus Inactive 25-Jul-2022 A61B3/13
To view Nova Eye Medical’s complete patent history, request access »

Nova Eye Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nova Eye Medical Investments & Acquisitions (3)

Nova Eye Medical’s most recent deal was a Corporate Asset Purchase with Innovative Glaucoma Solutions (Glaucoma Patents) for . The deal was made on 26-Aug-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Innovative Glaucoma Solutions (Glaucoma Patents) 26-Aug-2021 Corporate Asset Purchase Buildings and Property
Molteno (Molteno3 Glaucoma Drainage Device Platform) 02-Aug-2020 Corporate Asset Purchase Buildings and Property
iScience Interventional 31-Dec-2013 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Nova Eye Medical’s complete investments and acquisitions history, request access »

Nova Eye Medical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Nova Eye Medical’s complete esg history, request access »

Nova Eye Medical FAQs

  • When was Nova Eye Medical founded?

    Nova Eye Medical was founded in 1970.

  • Where is Nova Eye Medical headquartered?

    Nova Eye Medical is headquartered in Kent Town, Australia.

  • What is the size of Nova Eye Medical?

    Nova Eye Medical has 301 total employees.

  • What industry is Nova Eye Medical in?

    Nova Eye Medical’s primary industry is Surgical Devices.

  • Is Nova Eye Medical a private or public company?

    Nova Eye Medical is a Public company.

  • What is Nova Eye Medical’s stock symbol?

    The ticker symbol for Nova Eye Medical is EYE.

  • What is the current stock price of Nova Eye Medical?

    As of 19-Nov-2026 the stock price of Nova Eye Medical is $0.11.

  • What is the current market cap of Nova Eye Medical?

    The current market capitalization of Nova Eye Medical is $30.6M.

  • Who are Nova Eye Medical’s competitors?

    Wontech Co., Atricure, IRIDEX, DUKE Empirical, and Staar Surgical are some of the 8 competitors of Nova Eye Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process